BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16435115)

  • 1. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.
    Rubello D; Fanti S; Nanni C; Farsad M; Castellucci P; Boschi S; Franchi R; Mariani G; Fig LM; Gross MD
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):453-9. PubMed ID: 16435115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy.
    Fuster D; Ybarra J; Ortin J; Torregrosa JV; Gilabert R; Setoain X; Paredes P; Duch J; Pons F
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):467-73. PubMed ID: 16404597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
    J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.
    Otto D; Boerner AR; Hofmann M; Brunkhorst T; Meyer GJ; Petrich T; Scheumann GF; Knapp WH
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1405-12. PubMed ID: 15278308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.
    Vestergaard S; Gerke O; Bay M; Madsen AR; Stilgren L; Ejersted C; Rewers KI; Jakobsen N; Asmussen JT; Braad PE; Petersen H; Thomassen A; Schifter S
    Mol Imaging Biol; 2023 Aug; 25(4):720-726. PubMed ID: 36881250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
    Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
    Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis.
    Yuan L; Liu J; Kan Y; Yang J; Wang X
    Acta Radiol; 2017 May; 58(5):558-564. PubMed ID: 27589877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism.
    Yang J; Hao R; Yuan L; Li C; Yan J; Zhen L
    AJR Am J Roentgenol; 2014 Jan; 202(1):180-4. PubMed ID: 24370142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR; Obuchowski NA; Difilippo FP
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
    Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?
    Weber T; Gottstein M; Schwenzer S; Beer A; Luster M
    World J Surg; 2017 Apr; 41(4):980-985. PubMed ID: 27834016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
    Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D; Rubello D; Pelizzo MR; Shapiro B
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
    Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
    Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
    Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
    Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(99m)Tc]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations.
    Olaizola I; Zingraff J; Heuguerot C; Fajardo L; Léger A; Lopez J; Acuña G; Petraglia A; Alvarez A; Caorsi H; Drüeke T; Ambrosoni P
    Nephrol Dial Transplant; 2000 Aug; 15(8):1201-6. PubMed ID: 10910445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.
    Braeuning U; Pfannenberg C; Gallwitz B; Teichmann R; Mueller M; Dittmann H; Reimold M; Bares R
    Nuklearmedizin; 2015; 54(1):26-30. PubMed ID: 25427653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.